Monoclonal antibodies against heparin and heparinoids

Seminars in Thrombosis and Hemostasis

Volumn 23, Issue 1, 1997, Pages 17-22

  Huhle, Günter ^a   Harenberg, Job ^a   Malsch, Reinhard ^a   Heene, Dieter L ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

galactosaminoglycans; Glycosaminoglycans; heparin antibodies; iduronic acid; monoclonal antibodies

Indexed keywords

EPITOPE; GALACTOSAMINOGLYCAN; GLYCOSAMINOGLYCAN; HEPARIN; HEPARINOID; IDURONIC ACID; IMMUNOGLOBULIN G; IODINE 125; LOW MOLECULAR WEIGHT HEPARIN; MONOCLONAL ANTIBODY;

ANTIBODY PRODUCTION; ANTIGEN ANTIBODY COMPLEX; ANTIGEN BINDING; ANTIGENICITY; CONFERENCE PAPER; HYBRIDOMA; IMMUNIZATION; IMMUNOPRECIPITATION; ISOTOPE LABELING; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

EID: 0030984808     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-996065     Document Type: Conference Paper

References (31)

1. Kure S, O Yoshie: A syngeneic monoclonal antibody to murine Meth-A sarcoma (HepSS-1) recognizes heparan sulfate glycosaminoglycan (HS-GAG): Cell density and transformation dependent alteration in cell surface HS-GAG defined by HepSS-1. J Immunol 137:3900-3908, 1986.
2. Born van-den J, LP van den Heuvel, MA Bakker, JH Veerkamp, KJ Assmann, JH Berden: A monoclonal antibody against GBM heparan sulfate induces acute selective proteinuria in rats. Kidney Int 41:115-123, 1992.
3. Yagamata M, K Kimata, Y Oike, K Tani, N Maeda, K Yoshida, Y Shimomura, M Yoneda, S Suzuki: A monoclonal antibody that specifically recognizes a glucuronic acid 2-sulfate-containing determinant in intact chondroitin sulfate chain. J Biol Chem 262:4146-4152, 1987.
4. Caterson B, JE Christner, JR Baker: Identification of a monoclonal antibody that specifically recognizes corneal and skeletal keratan sulfate. J Biol Chem 258:8848-8854, 1983.
5. Mehmet H, P Scudder, PW Tang, EF Hounsell, B Caterson, T Feizi: The antigenic determinants recognized by three monoclonal antibodies to keratan sulphate involve sulphated hepta- or larger oligosaccharides of the poly(N-acetyllactosamine) series. Eur J Biochem 157:385-391, 1986.
6. Pejler G, U Lindahl, O Larm, E Scholander, E Sandgren, A Lundblad: Monoclonal antibodies specific for oligosaccharides prepared by partial nitrous acid deamination of heparin. J Biol Chem 263:5197-5201, 1988.
7. Gitel SN, VM Medina, S Wessler: Preparation and identification of a population of antibodies that recognize carbodiimide-modified heparin. Blood 65:902-911, 1985.
8. Strauss AH, LR Travassos, HK Takahashi: A monoclonal antibody (ST-1) directed to the native heparin chain. Anal Biochem 201:1-8, 1992.
9. Casu B: Structure of heparin and heparin fragments. Ann NY Acad Sci 556:1-17, 1989.
10. Linhardt RJ, ZM Merchant, KG Rice, YS Kim, GL Fitzgerald, AC Grant, R Langer: Evidence of random structural features in the heparin polymer. Biochemistry 24:7805-7810, 1985.
11. Harenberg J, JX de Vries: Characterization of heparins by high performance size exclusion liquid chromatography. J Chromatogr 261:287-292, 1983.
12. Malsch R, J Harenberg: Considerations about the correct nomenclature of glycosaminoglycans (GAGs). Thromb Haemostas 70:718-719, 1993.
13. Rosenberg RD: Role of heparin and heparinlike molecules in thrombosis and atherosclerosis. Fed Proc 36:10-18, 1977.
14. Thompson RW, A Orlidge, PA D'Amore: Heparin and growth control of vascular cells. Ann NY Acad Sci 556:255-267, 1989.
15. Linhardt RJ, KG Rice, YS Kin, J Engelken, J Weiler: Homogeneous, structurally defined heparin-oligosaccharides with low anticoagulant activity inhibit the generation of the amplification pathway C3 convertase in vitro. J Biol Chem 263:13090-13096, 1988.
16. Merchant ZM, EE Erbe, WP Eddy, D Patel, RJ Linhardt: Effect of very low molecular weight heparin-derived oligosaccharides on lipoprotein lipase release in rabbits. Atherosclerosis 62:151-158, 1986.
17. Baba M, R Pauwels, J Balzarini, J Arnout, E De Clerqu: Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro. Proc Natl Acad Sci USA 85:6132-6136, 1988.
18. Kakkar VV, A Cohen, RA Edmonson, MJ Phillips, DJ Cooper, SK Das, KT Maher, RM Sanderson, VP Ward, S Kakkar: Low molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal surgery. The Thromboprophylaxis Collaborative Group. Lancet 341:259-265, 1993.
19. Nourmohamed MT, FR Rosendall, HR Büller, E Dekker, DW Hommes, JP Vandenbroucke, E Briet: Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: A meta-analysis. Lancet 340:152-156, 1992.
20. THRIFT Consensus Group: Risk of and prophylaxis for venous thrombembolism in hospital patients. Thromboembolic Risk Factors (THRIFT) Consensus Group. Br Med J 305:567-573, 1992.
21. Harenberg J, P Roebruck, DL Heene: Subcutaneous low-molecular-weight heparin versus standard heparin and the prevention of thromboembolism in medical inpatients. Haemostasis 26: 127-139, 1996.
22. Hull R, GE Raskob, GF Pineo, D Green, A Trowbridge, CG Elliott, RG Lerner, J Hall, T Sparling, HR Brettell, J Norton, DJ Carter, R George, G Merli, J Ward, W Mayo, D Rosenbloom, R Brant: Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis. N Engl J Med 326:975-982, 1992.
23. Prandoni P, AWA Lensing, HR Büller, M Carta, A Cogo, M Vigo, D Casara, A Ruol, JW ten Cate: Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal-deep-vein thrombosis. Lancet 339:441-445, 1992.
24. Linhardt RJ: Heparin: An important drug enters its seventh decade. Chem Ind 2:45-50, 1991.
25. Harenberg J, R Malsch: German Patent P 4217916.5-43, 1993.
26. Malsch R, M Guerrini, G Torri, G Löhr, B Casu, J Harenberg: Synthesis of a N'-alkylamine anticoagulant active low-molecular-mass heparin for radioactive and fluorescent labeling. Anal Biochem 217:255-264, 1994.
27. Hunter WW, FC Greenwood: Preparation of iodine-131 labeled human growth hormone of high specific activity. Nature 194: 485-496, 1992.
28. Harenberg J, G Löhr, R Malsch, CE Dempfle, G Stehle, M Guerrini, G Torri, B Casu, DL Henne: Magnetic bead protamine-linked microtiter assay for detection of heparin using iodinated low-molecular-mass heparin-tyramine. Thromb Res 79:207-216, 1995.
29. Harenberg J, C Giese, A Knödler, R Zimmermann: Biological activity and safety of the subcutaneous administration of high doses of low molecular weight heparin for 8 days in human volunteers. Haemostasis 19:13-20, 1989.
30. 4 precipitation. In: Kenneth RH, TJ McKearn, KB Bechtol (Eds): Monoclonal Antibodies, Hybridomas: A New Dimension in Biological Analysis. Plenum Press, New York, 1982, pp 405-406.
31. Chaudhuri R, MD Green: A sensitive urea-silver stain method for detecting trace quantities of proteins in polyacrylamide gels. Prep Biochem 17:93-99, 1987.